Antibiotics: The Right Drug, The Right Patient, The Right Time
Preserving Kidneys. Protecting Lives. Combating Resistance.
“When every prescription is backed by science, every patient gets a better chance at recovery.”
Antibiotics have transformed modern medicine, making complex surgeries, organ transplantation, dialysis, cancer therapy, and critical care possible. However, the emergence of Antimicrobial Resistance (AMR) threatens these achievements. Responsible antibiotic selection is no longer an option—it is a clinical responsibility.
At Renasta Lifesciences, our anti-infective portfolio is designed to support evidence-based treatment across Nephrology, Urology, General Medicine, Surgery, ENT, and Dental practice, ensuring effective infection control while promoting antibiotic stewardship.
Why Antibiotic Stewardship Matters
The inappropriate use of antibiotics leads to:
- Rising antimicrobial resistance (AMR)
- Treatment failures
- Longer hospital stays
- Increased healthcare costs
- Greater risk of recurrent infections
- Reduced effectiveness of life-saving antibiotics
The guiding principle should always be:
Test when possible. Target the organism. Treat appropriately.
Nephrology & Urology: Where Every Antibiotic Decision Matters
Patients with Chronic Kidney Disease (CKD), dialysis, kidney transplant, diabetes, urinary obstruction, or recurrent UTIs are highly susceptible to infections.
” Precision Against Infection. Protection for Every Patient.”
The ideal antibiotic should offer:
- High urinary concentration
- Excellent renal tissue penetration
- Good safety profile
- Dose adjustment when required
- Lower risk of nephrotoxicity
- Minimal development of resistance
Renasta offers targeted options covering uncomplicated UTIs, recurrent UTIs and complicated bacterial infections.
ASTAMYSIN (Fosfomycin Trometamol 3 g)
One Dose. Powerful Action. Better Compliance.
Best suited for:
- Acute uncomplicated cystitis
- Recurrent UTIs
- Diabetic patients with UTI
- Elderly females
- High compliance situations
Why physicians prefer it:
- Single-dose oral therapy
- High urinary concentration
- Low resistance in common urinary pathogens
- Excellent patient convenience
- Minimal impact on normal flora
Ideal for:
- Nephrologists
- Urologists
- Physicians
- Gynecologists
ASTACEF-CV (Cefpodoxime + Clavulanate)
Smart choice for beta-lactamase producing organisms.
Useful in:
- Community-acquired respiratory infections
- Uncomplicated UTIs
- Skin & soft tissue infections
- Tonsillitis
- Pharyngitis
Clinical Advantages
- Broad Gram-positive & Gram-negative coverage
- Clavulanate protects against beta-lactamase enzymes
- Good oral bioavailability
- Excellent step-down therapy after injectable antibiotics
Ideal for:
- Physicians
- ENT Specialists
- Surgeons
- Pediatricians
ASTAMOX-CV (Amoxycillin + Clavulanate + Lactic Acid Bacillus)
Broad Spectrum Protection with Gut Care
A unique combination that not only fights infection but also helps reduce antibiotic-associated diarrhoea through probiotic support.
Effective against
- Respiratory tract infections
- Dental infections
- Otitis media
- Urinary tract infections
- Skin infections
Why Dentists & ENT Specialists Prefer It
- Excellent tissue penetration
- Proven efficacy
- Broad pathogen coverage
- Better gastrointestinal tolerance
Recommended for:
- Dentists
- ENT Specialists
- General Physicians
- Family Physicians
ASTAPENEM (Faropenem ER 200/300)
The Oral Penem Advantage
When stronger oral therapy is required, Faropenem provides excellent broad-spectrum coverage.
Effective in
- Lower respiratory tract infections
- Complicated UTIs
- ENT infections
- Mixed bacterial infections
- Skin & soft tissue infections
Clinical Benefits
- Stable against many beta-lactamases
- Excellent tissue penetration
- Convenient oral therapy
- Useful where resistance to conventional antibiotics is increasing
Preferred by:
- Surgeons
- Physicians
- Nephrologists
- Urologists
Specialty-Wise Clinical Relevance
Nephrologists
- Recurrent UTIs
- CKD-associated infections
- Catheter-associated infections
- Diabetic nephropathy patients
Urologists
- Acute cystitis
- Recurrent UTI
- Post-procedure infections
- Complicated urinary infections
General Physicians
- Respiratory infections
- Community-acquired bacterial infections
- Mixed infections
- Early outpatient management
Surgeons
- Surgical site infection management
- Step-down oral antibiotic therapy
- Skin & soft tissue infections
ENT Specialists
- Tonsillitis
- Otitis media
- Sinusitis
- Pharyngitis
Dentists
- Dental abscess
- Periodontal infections
- Odontogenic infections
- Post-extraction prophylaxis (where clinically indicated)
Renasta’s Commitment to Responsible Antibiotic Use
At Renasta Lifesciences, we believe antibiotics should be used judiciously, ensuring maximum clinical benefit while preserving their effectiveness for future generations.
Our Antibiotic Stewardship Principles
Right Antibiotic
Right Patient
Right Dose
Right Duration
Right Indication
Right Time
Together Against Antimicrobial Resistance
Antibiotic resistance is not just a hospital issue—it is a global healthcare challenge. Every healthcare professional has a role in safeguarding the effectiveness of antibiotics.
“Target the Infection. Preserve the Kidneys. Protect the Future.”
Renasta Lifesciences – Advancing Responsible Antibiotic Therapy Across Nephrology, Urology, Surgery, ENT, Dentistry & General Medicine.
